All lobbying filings
Miller Strategies, LLC
Miller Strategies, LLC filed a Q3 report for Bristol-Myers Squibb Company on October 20, 2026.
Lobbying for Bristol-Myers Squibb Company · Biopharmaceutical company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
New Jersey
Lobbying activity
2
Issues related to biosimilars reimbursement, supply chain and Medicare/Medicaid payment reform.
Issues related to biosimilars reimbursement, supply chain and Medicare/Medicaid payment reform.